NCT00944346View on ClinicalTrials.gov

Study to Evaluate the Bioequivalence of a Test Tablet Formulation of Metformin HCl (1000 mg), Compared to an Equivalent Dose of a Commercially Available Reference Drug Product (Glucophage®, Bristol-Myers Squibb Company) in Fed, Healthy, Adult Subjects

PHASE1CompletedINTERVENTIONAL

Timeline

Start Date

Not specified

Conditions

Healthy

Interventions

DRUG

Metformin HCl

Trial Locations (1)

Unknown

Gateway Medical Research, Inc., Saint Charles

All Listed Sponsors

lead

Torrent Pharmaceuticals Limited

INDUSTRY

NCT00944346 - Study to Evaluate the Bioequivalence of a Test Tablet Formulation of Metformin HCl (1000 mg), Compared to an Equivalent Dose of a Commercially Available Reference Drug Product (Glucophage®, Bristol-Myers Squibb Company) in Fed, Healthy, Adult Subjects | Biotech Hunter | Biotech Hunter